Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2013 1
2014 5
2015 3
2016 3
2017 4
2018 4
2019 5
2020 6
2021 6
2022 10
2023 7
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacosurveillance in Juvenile Idiopathic Arthritis.
Shiff NJ, Beukelman T. Shiff NJ, et al. Rheum Dis Clin North Am. 2021 Nov;47(4):643-653. doi: 10.1016/j.rdc.2021.07.012. Epub 2021 Sep 2. Rheum Dis Clin North Am. 2021. PMID: 34635296 Review.
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study.
Coates LC, Gossec L, Zimmermann M, Shawi M, Rampakakis E, Shiff NJ, Kollmeier AP, Xu XL, Nash P, Mease PJ, Helliwell PS. Coates LC, et al. Among authors: shiff nj. RMD Open. 2024 Mar 26;10(1):e003977. doi: 10.1136/rmdopen-2023-003977. RMD Open. 2024. PMID: 38531621 Free PMC article. Clinical Trial.
Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
Cellucci T, Guzman J, Petty RE, Batthish M, Benseler SM, Ellsworth JE, Houghton KM, LeBLANC CM, Huber AM, Luca N, Schmeling H, Shiff NJ, Soon GS, Tse SM; Pediatric Committee of the Canadian Rheumatology Association. Cellucci T, et al. Among authors: shiff nj. J Rheumatol. 2016 Oct;43(10):1773-1776. doi: 10.3899/jrheum.160074. J Rheumatol. 2016. PMID: 27698103 Review. No abstract available.
A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
Nguyen K, Barsalou J, Basodan D, Batthish M, Benseler SM, Berard RA, Blanchette N, Boire G, Bolaria R, Bruns A, Cabral DA, Cameron B, Campillo S, Cellucci T, Chan M, Chédeville G, Chetaille AL, Chhabra A, Couture J, Dancey P, De Bruycker JJ, Demirkaya E, Dhalla M, Duffy CM, Feldman BM, Feldman DE, Gerschman T, Haddad E, Heale L, Herrington J, Houghton K, Huber AM, Human A, Johnson N, Jurencak R, Lang B, Larché M, Laxer RM, LeBlanc CM, Lee JJY, Levy DM, Lim L, Lim LSH, Luca N, McGrath T, McMillan T, Miettunen PM, Morishita KA, Ng HY, Oen K, Park J, Petty RE, Proulx-Gauthier JP, Ramsey S, Roth J, Rosenberg AM, Rozenblyum E, Rumsey DG, Schmeling H, Schneider R, Scuccimarri R, Shiff NJ, Silverman E, Soon G, Spiegel L, Stringer E, Tam H, Tse SM, Tucker LB, Turvey S, Twilt M, Duffy KW, Yeung RSM, Guzman J. Nguyen K, et al. Among authors: shiff nj. Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI173-SI179. doi: 10.1093/rheumatology/kead560. Rheumatology (Oxford). 2024. PMID: 37851400 Free PMC article.
Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ, Ogdie A, Tesser J, Shiff NJ, Zhao RS, Chakravarty SD, Kelleman M, Dodge R, McLean RR, Broadwell A, Kavanaugh A, Merola JF. Mease PJ, et al. Among authors: shiff nj. ACR Open Rheumatol. 2024 May;6(5):304-311. doi: 10.1002/acr2.11657. Epub 2024 Feb 28. ACR Open Rheumatol. 2024. PMID: 38417434 Free PMC article.
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors.
Walsh JA, Lin I, Zhao R, Shiff NJ, Morrison L, Emond B, Yu LH, Schwartzbein S, Lefebvre P, Pilon D, Chakravarty SD, Mease P. Walsh JA, et al. Among authors: shiff nj. Drugs Real World Outcomes. 2024 Sep;11(3):487-499. doi: 10.1007/s40801-024-00428-z. Epub 2024 Jul 31. Drugs Real World Outcomes. 2024. PMID: 39083163 Free PMC article.
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort.
McGrath T, Guzman J, Tucker L, Shiff NJ, Yaskina M, Tupper S, Rumsey DG; Research in Arthritis in Canadian Children Emphasizing Outcomes (ReACCh-Out) Investigators. McGrath T, et al. Among authors: shiff nj. Pediatr Rheumatol Online J. 2023 Sep 16;21(1):102. doi: 10.1186/s12969-023-00885-w. Pediatr Rheumatol Online J. 2023. PMID: 37715224 Free PMC article.
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ, Ogdie A, Tesser J, Shiff NJ, Lin I, Chakravarty SD, Kelleman M, Dodge R, McLean RR, Broadwell A, Kavanaugh A, Merola JF. Mease PJ, et al. Among authors: shiff nj. Rheumatol Ther. 2023 Dec;10(6):1479-1501. doi: 10.1007/s40744-023-00582-w. Epub 2023 Aug 19. Rheumatol Ther. 2023. PMID: 37597159 Free PMC article.
59 results